Exact Mass: 515.2672

Taurocholate

C26H45NO7S (515.2917)

Taurocholic acid is a bile acid and is the product of the conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of taurocholate in fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and sudden intra-uterine death (PMID: 3944741, 11256973). Taurocholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=81-24-3 (retrieved 2024-07-01) (CAS RN: 81-24-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.

Taurohyocholate

C26H45NO7S (515.2917)

Taurohyocholate is a bile acid. It is a product of the metabolism of Taurochenodeoxycholate which is catalyzed by the enzyme CYP3A4. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB] Taurohyocholate is a bile acid. It is a product of the metabolism of Taurochenodeoxycholate which is catalyzed by the enzyme CYP3A4. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). CONFIDENCE standard compound; INTERNAL_ID 268

Ciliatocholic acid

C26H46NO7P (515.3012)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

Candoxatril

C29H41NO7 (515.2883)

Candoxatril is only found in individuals that have used or taken this drug. It is the orally-active prodrug of candoxatrilat (UK-73967), the active enantiomer of candoxatrilat (UK-69578), a potent neutral endopeptidase (NEP) inhibitor used in the treatment of chronic heart failure.Neutral endopeptidase inhibitors such as Candoxatril have a dual mechanism of action. They inhibit two metalloprotease enzymes, neutral endopeptidase and ACE, resulting in an increased availability of natriuretic peptides that exhibit vasodilatory effects and, possibly, tissue protective effects. D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

Tauro-β-muricholic acid

C26H45NO7S (515.2917)

Tauro-b-muricholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Tauro-b-muricholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

Tauroursocholic acid

C26H45NO7S (515.2917)

Tauroursocholic acid is a bile acid formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Tauroursocholic acid is a bile acid formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB]

Taurallocholic acid

C26H45NO7S (515.2917)

Taurallocholic acid, also known as taurallocholate, belongs to the class of organic compounds known as taurinated bile acids and derivatives. These are bile acid derivatives containing a taurine conjugated to the bile acid moiety. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Taurallocholic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Taurallocholic acid is an ethanesulfonic acid derivative of cholane. An ethanesulfonic acid derivative of Cholane. Tauroallocholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. [HMDB]

LysoPC(18:4(6Z,9Z,12Z,15Z)/0:0)

C26H46NO7P (515.3012)

LysoPC(18:4(6Z,9Z,12Z,15Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(18:4(6Z,9Z,12Z,15Z)), in particular, consists of one chain of stearidonic acid at the C-1 position. The stearidonic acid moiety is derived from seed oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

Perphenazine enanthate

C28H38ClN3O2S (515.2373)

2-[(3alpha,7alpha,12alpha-Trihydroxy-24-oxocholane-24-yl)amino]ethanesulfonic acid

C26H45NO7S (515.2917)

Tauro-α-muricholic acid

C26H45NO7S (515.2917)

3-(1-((4-Carboxycyclohexyl)carbamoyl)cyclopentyl)-2-(2-methoxyethoxymethyl)propanoic acid 5-indanyl ester

C29H41NO7 (515.2883)

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

Taurocholic Acid

C26H45NO7S (515.2917)

D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.

Desoxyharringtonin

C28H37NO8 (515.2519)

11-Hydroxydeoxyharringtonine

C28H37NO8 (515.2519)

2-[(3R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid

C28H37NO8 (515.2519)

C29H41NO7

C29H41NO7 (515.2883)

Asterinin D

C25H33N5O7 (515.238)

Condurangamine A

C29H41NO7 (515.2883)

Rostratin

C28H37NO8 (515.2519)

3alpha,7alpha,9alpha-trihydroxy-5beta-cholan-24-oic acid N-[2-sulfoethyl] amide

C26H45NO7S (515.2917)

Alkaloid GB12

C28H37NO8 (515.2519)

SCHEMBL17866856

C26H37N5O6 (515.2744)

C25H33N5O7

C25H33N5O7 (515.238)

N-(3alpha,7alpha,15alpha-trihydroxy-5beta-cholan-24-oyl)taurine

C26H45NO7S (515.2917)

3alpha,5,7alpha-trihydroxy-5beta-cholan-24-oic acid N-[2-sulfoethyl] amide|tauroansocholic acid

C26H45NO7S (515.2917)

Spirodihydrobenzofuranlactam IV

C28H37NO8 (515.2519)

Gly Ala Asn Val Arg

C20H37N9O7 (515.2816)

Gly Val Val Glu Ile

C23H41N5O8 (515.2955)

Gly Asp Ile Val Ile

C23H41N5O8 (515.2955)

Taurocholate

C26H45NO7S (515.2917)

C28H37NO8_Pentanedioic acid, 2-[(6S,8aS)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxospiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-7(3H)-yl]

C28H37NO8 (515.2519)

C28H37NO8_2-{2-[(3E)-4,8-Dimethyl-3,7-nonadien-1-yl]-3,5-dihydroxy-2-methyl-7-oxo-3,4,7,9-tetrahydropyrano[2,3-e]isoindol-8(2H)-yl}pentanedioic acid

C28H37NO8 (515.2519)

C25H33N5O7_2-({3-Phenyl-3-[(N-{2-[(1H-pyrrol-2-ylcarbonyl)amino]butanoyl}seryl)amino]propanoyl}amino)butanoic acid

C25H33N5O7 (515.238)

C28H37NO8_2-[(6R,8aS)-4,6-Dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl]pentanedioic acid

C28H37NO8 (515.2519)

C28H37NO8_Pentanedioic acid, 2-[(2R,2R,6R,8aS)-3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxospiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalen]-7(3H)-yl]-, (2S)

C28H37NO8 (515.2519)

Taurocholic Acid

C26H45NO7S (515.2917)

A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals. D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; WBWWGRHZICKQGZ-HZAMXZRMSA-N_STSL_0093_Taurocholic acid_8000fmol_180416_S2_LC02_MS02_101; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. CONFIDENCE standard compound; INTERNAL_ID 59 Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.

(2S)-2-[(3R,7R,8R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid

C28H37NO8 (515.2519)

Tauromuricholic acid

C26H45NO7S (515.2917)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 69 CONFIDENCE standard compound; INTERNAL_ID 67 CONFIDENCE standard compound; INTERNAL_ID 65

2-{[(3Alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino}ethanesulfonic acid

C26H45NO7S (515.2917)

BA-138-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-138-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-138-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-138-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

Nargenicin A1

C28H37NO8 (515.2519)

Tauroallocholic acid

C26H45NO7S (515.2917)

Tauroursocholic acid

C26H45NO7S (515.2917)

A bile acid taurine conjugate of ursocholic acid.

candoxatril

C29H41NO7 (515.2883)

D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9663; ORIGINAL_PRECURSOR_SCAN_NO 9662 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9679; ORIGINAL_PRECURSOR_SCAN_NO 9676 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9678; ORIGINAL_PRECURSOR_SCAN_NO 9675 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9724; ORIGINAL_PRECURSOR_SCAN_NO 9721 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9734; ORIGINAL_PRECURSOR_SCAN_NO 9733 CONFIDENCE standard compound; INTERNAL_ID 1151; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9729; ORIGINAL_PRECURSOR_SCAN_NO 9727

Taurocholic acid; LC-tDDA; CE10

C26H45NO7S (515.2917)

Taurocholic acid; LC-tDDA; CE20

C26H45NO7S (515.2917)

Taurocholic acid; LC-tDDA; CE30

C26H45NO7S (515.2917)

Taurocholic acid; LC-tDDA; CE40

C26H45NO7S (515.2917)

(2S)-2-[(3R,7R,8R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid_major

C28H37NO8 (515.2519)

2-[(3R,8aS)-3,4-dihydroxy-4,4,7,8a-tetramethyl-6-oxospiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-3,8-dihydrofuro[2,3-e]isoindole]-7-yl]pentanedioic acid_major

C28H37NO8 (515.2519)

2-((R)-4-((3R,5S,7R,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5R,6S,7S,9S,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5S,7R,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5R,7R,8R,9S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((4R)-4-((3R,5S,7R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

Taurohyocholic acid

C26H45NO7S (515.2917)

Ala Asn Arg Arg

C19H37N11O6 (515.2928)

Ala Arg Asn Arg

C19H37N11O6 (515.2928)

Ala Arg Arg Asn

C19H37N11O6 (515.2928)

Atracurium (Quaternary alcohol)

C29H41NO7 (515.2883)

Asp Glu Pro Arg

C20H33N7O9 (515.234)

Asp Glu Arg Pro

C20H33N7O9 (515.234)

Asp Pro Glu Arg

C20H33N7O9 (515.234)

Asp Pro Arg Glu

C20H33N7O9 (515.234)

Asp Pro Val Trp

C25H33N5O7 (515.238)

Asp Pro Trp Val

C25H33N5O7 (515.238)

Asp Arg Glu Pro

C20H33N7O9 (515.234)

Asp Arg Pro Glu

C20H33N7O9 (515.234)

Asp Val Pro Trp

C25H33N5O7 (515.238)

Asp Val Trp Pro

C25H33N5O7 (515.238)

Asp Trp Pro Val

C25H33N5O7 (515.238)

Asp Trp Val Pro

C25H33N5O7 (515.238)

Glu Asp Pro Arg

C20H33N7O9 (515.234)

Glu Asp Arg Pro

C20H33N7O9 (515.234)

Glu Pro Asp Arg

C20H33N7O9 (515.234)

Glu Pro Arg Asp

C20H33N7O9 (515.234)

Glu Arg Asp Pro

C20H33N7O9 (515.234)

Glu Arg Pro Asp

C20H33N7O9 (515.234)

Phe Gly His Arg

C23H33N9O5 (515.2605)

Phe Gly Arg His

C23H33N9O5 (515.2605)

Phe His Gly Arg

C23H33N9O5 (515.2605)

Phe His Asn Val

C24H33N7O6 (515.2492)

Phe His Arg Gly

C23H33N9O5 (515.2605)

Phe His Val Asn

C24H33N7O6 (515.2492)

Phe Asn His Val

C24H33N7O6 (515.2492)

Phe Asn Val His

C24H33N7O6 (515.2492)

Phe Pro Pro Arg

C25H37N7O5 (515.2856)

Phe Pro Arg Pro

C25H37N7O5 (515.2856)

Phe Arg Gly His

C23H33N9O5 (515.2605)

Phe Arg His Gly

C23H33N9O5 (515.2605)

Phe Arg Pro Pro

C25H37N7O5 (515.2856)

Phe Val His Asn

C24H33N7O6 (515.2492)

Phe Val Asn His

C24H33N7O6 (515.2492)

Gly Phe His Arg

C23H33N9O5 (515.2605)

Gly Phe Arg His

C23H33N9O5 (515.2605)

Gly His Phe Arg

C23H33N9O5 (515.2605)

Gly His Arg Phe

C23H33N9O5 (515.2605)

Gly Gln Arg Arg

C19H37N11O6 (515.2928)

Gly Arg Phe His

C23H33N9O5 (515.2605)

Gly Arg His Phe

C23H33N9O5 (515.2605)

Gly Arg Gln Arg

C19H37N11O6 (515.2928)

Gly Arg Arg Gln

C19H37N11O6 (515.2928)

His Phe Gly Arg

C23H33N9O5 (515.2605)

His Phe Asn Val

C24H33N7O6 (515.2492)

His Phe Arg Gly

C23H33N9O5 (515.2605)

His Phe Val Asn

C24H33N7O6 (515.2492)

His Gly Phe Arg

C23H33N9O5 (515.2605)

His Gly Arg Phe

C23H33N9O5 (515.2605)

His Lys Met Thr

C21H37N7O6S (515.2526)

His Lys Thr Met

C21H37N7O6S (515.2526)

His Met Lys Thr

C21H37N7O6S (515.2526)

His Met Thr Lys

C21H37N7O6S (515.2526)

His Asn Phe Val

C24H33N7O6 (515.2492)

His Asn Val Phe

C24H33N7O6 (515.2492)

His Arg Phe Gly

C23H33N9O5 (515.2605)

His Arg Gly Phe

C23H33N9O5 (515.2605)

His Thr Lys Met

C21H37N7O6S (515.2526)

His Thr Met Lys

C21H37N7O6S (515.2526)

His Val Phe Asn

C24H33N7O6 (515.2492)

His Val Asn Phe

C24H33N7O6 (515.2492)

Ile Met Pro Arg

C22H41N7O5S (515.289)

Ile Met Arg Pro

C22H41N7O5S (515.289)

Ile Asn Asn Arg

C20H37N9O7 (515.2816)

Ile Asn Arg Asn

C20H37N9O7 (515.2816)

Ile Pro Met Arg

C22H41N7O5S (515.289)

Ile Pro Arg Met

C22H41N7O5S (515.289)

Ile Pro Thr Trp

C26H37N5O6 (515.2744)

Ile Pro Trp Thr

C26H37N5O6 (515.2744)

Ile Gln Gln Gln

C21H37N7O8 (515.2703)

Ile Arg Met Pro

C22H41N7O5S (515.289)

Ile Arg Asn Asn

C20H37N9O7 (515.2816)

Ile Arg Pro Met

C22H41N7O5S (515.289)

Ile Thr Pro Trp

C26H37N5O6 (515.2744)

Ile Thr Trp Pro

C26H37N5O6 (515.2744)

Ile Trp Pro Thr

C26H37N5O6 (515.2744)

Ile Trp Thr Pro

C26H37N5O6 (515.2744)

Lys His Met Thr

C21H37N7O6S (515.2526)

Lys His Thr Met

C21H37N7O6S (515.2526)

Lys Met His Thr

C21H37N7O6S (515.2526)

Lys Met Thr His

C21H37N7O6S (515.2526)

Lys Thr His Met

C21H37N7O6S (515.2526)

Lys Thr Met His

C21H37N7O6S (515.2526)

Leu Met Pro Arg

C22H41N7O5S (515.289)

Leu Met Arg Pro

C22H41N7O5S (515.289)

Leu Asn Asn Arg

C20H37N9O7 (515.2816)

Leu Asn Arg Asn

C20H37N9O7 (515.2816)

Leu Pro Met Arg

C22H41N7O5S (515.289)

Leu Pro Arg Met

C22H41N7O5S (515.289)

Leu Pro Thr Trp

C26H37N5O6 (515.2744)

Leu Pro Trp Thr

C26H37N5O6 (515.2744)

Leu Gln Gln Gln

C21H37N7O8 (515.2703)

Leu Arg Met Pro

C22H41N7O5S (515.289)

Leu Arg Asn Asn

C20H37N9O7 (515.2816)

Leu Arg Pro Met

C22H41N7O5S (515.289)

Leu Thr Pro Trp

C26H37N5O6 (515.2744)

Leu Thr Trp Pro

C26H37N5O6 (515.2744)

Leu Trp Pro Thr

C26H37N5O6 (515.2744)

Leu Trp Thr Pro

C26H37N5O6 (515.2744)

Met His Lys Thr

C21H37N7O6S (515.2526)

Met His Thr Lys

C21H37N7O6S (515.2526)

Met Ile Pro Arg

C22H41N7O5S (515.289)

Met Ile Arg Pro

C22H41N7O5S (515.289)

Met Lys His Thr

C21H37N7O6S (515.2526)

Met Lys Thr His

C21H37N7O6S (515.2526)

Met Leu Pro Arg

C22H41N7O5S (515.289)

Met Leu Arg Pro

C22H41N7O5S (515.289)

Met Pro Ile Arg

C22H41N7O5S (515.289)

Met Pro Leu Arg

C22H41N7O5S (515.289)

Met Pro Arg Ile

C22H41N7O5S (515.289)

Met Pro Arg Leu

C22H41N7O5S (515.289)

Met Arg Ile Pro

C22H41N7O5S (515.289)

Met Arg Leu Pro

C22H41N7O5S (515.289)

Met Arg Pro Ile

C22H41N7O5S (515.289)

Met Arg Pro Leu

C22H41N7O5S (515.289)

Met Thr His Lys

C21H37N7O6S (515.2526)

Met Thr Lys His

C21H37N7O6S (515.2526)

Asn Ala Arg Arg

C19H37N11O6 (515.2928)

Asn Phe His Val

C24H33N7O6 (515.2492)

Asn Phe Val His

C24H33N7O6 (515.2492)

Asn His Phe Val

C24H33N7O6 (515.2492)

Asn His Val Phe

C24H33N7O6 (515.2492)

Asn Ile Asn Arg

C20H37N9O7 (515.2816)

Asn Ile Arg Asn

C20H37N9O7 (515.2816)

Asn Leu Asn Arg

C20H37N9O7 (515.2816)

Asn Leu Arg Asn

C20H37N9O7 (515.2816)

Asn Asn Ile Arg

C20H37N9O7 (515.2816)

Asn Asn Leu Arg

C20H37N9O7 (515.2816)

Asn Asn Arg Ile

C20H37N9O7 (515.2816)

Asn Asn Arg Leu

C20H37N9O7 (515.2816)

Asn Gln Arg Val

C20H37N9O7 (515.2816)

Asn Gln Val Arg

C20H37N9O7 (515.2816)

Asn Arg Ala Arg

C19H37N11O6 (515.2928)

Asn Arg Ile Asn

C20H37N9O7 (515.2816)

Asn Arg Leu Asn

C20H37N9O7 (515.2816)

Asn Arg Asn Ile

C20H37N9O7 (515.2816)

Asn Arg Asn Leu

C20H37N9O7 (515.2816)

Asn Arg Gln Val

C20H37N9O7 (515.2816)

Asn Arg Arg Ala

C19H37N11O6 (515.2928)

Asn Arg Val Gln

C20H37N9O7 (515.2816)

Asn Val Phe His

C24H33N7O6 (515.2492)

Asn Val His Phe

C24H33N7O6 (515.2492)

Asn Val Gln Arg

C20H37N9O7 (515.2816)

Asn Val Arg Gln

C20H37N9O7 (515.2816)

Pro Asp Glu Arg

C20H33N7O9 (515.234)

Pro Asp Arg Glu

C20H33N7O9 (515.234)

Pro Asp Val Trp

C25H33N5O7 (515.238)

Pro Asp Trp Val

C25H33N5O7 (515.238)

Pro Glu Asp Arg

C20H33N7O9 (515.234)

Pro Glu Arg Asp

C20H33N7O9 (515.234)

Pro Phe Pro Arg

C25H37N7O5 (515.2856)

Pro Phe Arg Pro

C25H37N7O5 (515.2856)

Pro Ile Met Arg

C22H41N7O5S (515.289)

Pro Ile Arg Met

C22H41N7O5S (515.289)

Pro Ile Thr Trp

C26H37N5O6 (515.2744)

Pro Ile Trp Thr

C26H37N5O6 (515.2744)

Pro Leu Met Arg

C22H41N7O5S (515.289)

Pro Leu Arg Met

C22H41N7O5S (515.289)

Pro Leu Thr Trp

C26H37N5O6 (515.2744)

Pro Leu Trp Thr

C26H37N5O6 (515.2744)

Pro Met Ile Arg

C22H41N7O5S (515.289)

Pro Met Leu Arg

C22H41N7O5S (515.289)

Pro Met Arg Ile

C22H41N7O5S (515.289)

Pro Met Arg Leu

C22H41N7O5S (515.289)

Pro Pro Phe Arg

C25H37N7O5 (515.2856)

Pro Pro Arg Phe

C25H37N7O5 (515.2856)

Pro Arg Asp Glu

C20H33N7O9 (515.234)

Pro Arg Glu Asp

C20H33N7O9 (515.234)

Pro Arg Phe Pro

C25H37N7O5 (515.2856)

Pro Arg Ile Met

C22H41N7O5S (515.289)

Pro Arg Leu Met

C22H41N7O5S (515.289)

Pro Arg Met Ile

C22H41N7O5S (515.289)

Pro Arg Met Leu

C22H41N7O5S (515.289)

Pro Arg Pro Phe

C25H37N7O5 (515.2856)

Pro Thr Ile Trp

C26H37N5O6 (515.2744)

Pro Thr Leu Trp

C26H37N5O6 (515.2744)

Pro Thr Trp Ile

C26H37N5O6 (515.2744)

Pro Thr Trp Leu

C26H37N5O6 (515.2744)

Pro Val Asp Trp

C25H33N5O7 (515.238)

Pro Val Trp Asp

C25H33N5O7 (515.238)

Pro Trp Asp Val

C25H33N5O7 (515.238)

Pro Trp Ile Thr

C26H37N5O6 (515.2744)

Pro Trp Leu Thr

C26H37N5O6 (515.2744)

Pro Trp Thr Ile

C26H37N5O6 (515.2744)

Pro Trp Thr Leu

C26H37N5O6 (515.2744)

Pro Trp Val Asp

C25H33N5O7 (515.238)

Gln Gly Arg Arg

C19H37N11O6 (515.2928)

Gln Ile Gln Gln

C21H37N7O8 (515.2703)

Gln Leu Gln Gln

C21H37N7O8 (515.2703)

Gln Asn Arg Val

C20H37N9O7 (515.2816)

Gln Asn Val Arg

C20H37N9O7 (515.2816)

Gln Gln Ile Gln

C21H37N7O8 (515.2703)

Gln Gln Leu Gln

C21H37N7O8 (515.2703)

Gln Gln Gln Ile

C21H37N7O8 (515.2703)

Gln Gln Gln Leu

C21H37N7O8 (515.2703)

Gln Arg Gly Arg

C19H37N11O6 (515.2928)

Gln Arg Asn Val

C20H37N9O7 (515.2816)

Gln Arg Arg Gly

C19H37N11O6 (515.2928)

Gln Arg Val Asn

C20H37N9O7 (515.2816)

Gln Val Asn Arg

C20H37N9O7 (515.2816)

Gln Val Arg Asn

C20H37N9O7 (515.2816)

Arg Ala Asn Arg

C19H37N11O6 (515.2928)

Arg Ala Arg Asn

C19H37N11O6 (515.2928)

Arg Asp Glu Pro

C20H33N7O9 (515.234)

Arg Asp Pro Glu

C20H33N7O9 (515.234)

Arg Glu Asp Pro

C20H33N7O9 (515.234)

Arg Glu Pro Asp

C20H33N7O9 (515.234)

Arg Phe Gly His

C23H33N9O5 (515.2605)

Arg Phe His Gly

C23H33N9O5 (515.2605)

Arg Phe Pro Pro

C25H37N7O5 (515.2856)

Arg Gly Phe His

C23H33N9O5 (515.2605)

Arg Gly His Phe

C23H33N9O5 (515.2605)

Arg Gly Gln Arg

C19H37N11O6 (515.2928)

Arg Gly Arg Gln

C19H37N11O6 (515.2928)

Arg His Phe Gly

C23H33N9O5 (515.2605)

Arg His Gly Phe

C23H33N9O5 (515.2605)

Arg Ile Met Pro

C22H41N7O5S (515.289)

Arg Ile Asn Asn

C20H37N9O7 (515.2816)

Arg Ile Pro Met

C22H41N7O5S (515.289)

Arg Leu Met Pro

C22H41N7O5S (515.289)

Arg Leu Asn Asn

C20H37N9O7 (515.2816)

Arg Leu Pro Met

C22H41N7O5S (515.289)

Arg Met Ile Pro

C22H41N7O5S (515.289)

Arg Met Leu Pro

C22H41N7O5S (515.289)

Arg Met Pro Ile

C22H41N7O5S (515.289)

Arg Met Pro Leu

C22H41N7O5S (515.289)

Arg Asn Ala Arg

C19H37N11O6 (515.2928)

Arg Asn Ile Asn

C20H37N9O7 (515.2816)

Arg Asn Leu Asn

C20H37N9O7 (515.2816)

Arg Asn Asn Ile

C20H37N9O7 (515.2816)

Arg Asn Asn Leu

C20H37N9O7 (515.2816)

Arg Asn Gln Val

C20H37N9O7 (515.2816)

Arg Asn Arg Ala

C19H37N11O6 (515.2928)

Arg Asn Val Gln

C20H37N9O7 (515.2816)

Arg Pro Asp Glu

C20H33N7O9 (515.234)

Arg Pro Glu Asp

C20H33N7O9 (515.234)

Arg Pro Phe Pro

C25H37N7O5 (515.2856)

Arg Pro Ile Met

C22H41N7O5S (515.289)

Arg Pro Leu Met

C22H41N7O5S (515.289)

Arg Pro Met Ile

C22H41N7O5S (515.289)

Arg Pro Met Leu

C22H41N7O5S (515.289)

Arg Pro Pro Phe

C25H37N7O5 (515.2856)

Arg Gln Gly Arg

C19H37N11O6 (515.2928)

Arg Gln Asn Val

C20H37N9O7 (515.2816)

Arg Gln Arg Gly

C19H37N11O6 (515.2928)

Arg Gln Val Asn

C20H37N9O7 (515.2816)

Arg Arg Ala Asn

C19H37N11O6 (515.2928)

Arg Arg Gly Gln

C19H37N11O6 (515.2928)

Arg Arg Asn Ala

C19H37N11O6 (515.2928)

Arg Arg Gln Gly

C19H37N11O6 (515.2928)

Arg Val Asn Gln

C20H37N9O7 (515.2816)

Arg Val Gln Asn

C20H37N9O7 (515.2816)

Thr His Lys Met

C21H37N7O6S (515.2526)

Thr His Met Lys

C21H37N7O6S (515.2526)

Thr Ile Pro Trp

C26H37N5O6 (515.2744)

Thr Ile Trp Pro

C26H37N5O6 (515.2744)

Thr Lys His Met

C21H37N7O6S (515.2526)

Thr Lys Met His

C21H37N7O6S (515.2526)

Thr Leu Pro Trp

C26H37N5O6 (515.2744)

Thr Leu Trp Pro

C26H37N5O6 (515.2744)

Thr Met His Lys

C21H37N7O6S (515.2526)

Thr Met Lys His

C21H37N7O6S (515.2526)

Thr Pro Ile Trp

C26H37N5O6 (515.2744)

Thr Pro Leu Trp

C26H37N5O6 (515.2744)

Thr Pro Trp Ile

C26H37N5O6 (515.2744)

Thr Pro Trp Leu

C26H37N5O6 (515.2744)

Thr Trp Ile Pro

C26H37N5O6 (515.2744)

Thr Trp Leu Pro

C26H37N5O6 (515.2744)

Thr Trp Pro Ile

C26H37N5O6 (515.2744)

Thr Trp Pro Leu

C26H37N5O6 (515.2744)

Val Asp Pro Trp

C25H33N5O7 (515.238)

Val Asp Trp Pro

C25H33N5O7 (515.238)

Val Phe His Asn

C24H33N7O6 (515.2492)

Val Phe Asn His

C24H33N7O6 (515.2492)

Val His Phe Asn

C24H33N7O6 (515.2492)

Val His Asn Phe

C24H33N7O6 (515.2492)

Val Asn Phe His

C24H33N7O6 (515.2492)

Val Asn His Phe

C24H33N7O6 (515.2492)

Val Asn Gln Arg

C20H37N9O7 (515.2816)

Val Asn Arg Gln

C20H37N9O7 (515.2816)

Val Pro Asp Trp

C25H33N5O7 (515.238)

Val Pro Trp Asp

C25H33N5O7 (515.238)

Val Gln Asn Arg

C20H37N9O7 (515.2816)

Val Gln Arg Asn

C20H37N9O7 (515.2816)

Val Arg Asn Gln

C20H37N9O7 (515.2816)

Val Arg Gln Asn

C20H37N9O7 (515.2816)

Val Trp Asp Pro

C25H33N5O7 (515.238)

Val Trp Pro Asp

C25H33N5O7 (515.238)

Trp Asp Pro Val

C25H33N5O7 (515.238)

Trp Asp Val Pro

C25H33N5O7 (515.238)

Trp Ile Pro Thr

C26H37N5O6 (515.2744)

Trp Ile Thr Pro

C26H37N5O6 (515.2744)

Trp Leu Pro Thr

C26H37N5O6 (515.2744)

Trp Leu Thr Pro

C26H37N5O6 (515.2744)

Trp Pro Asp Val

C25H33N5O7 (515.238)

Trp Pro Ile Thr

C26H37N5O6 (515.2744)

Trp Pro Leu Thr

C26H37N5O6 (515.2744)

Trp Pro Thr Ile

C26H37N5O6 (515.2744)

Trp Pro Thr Leu

C26H37N5O6 (515.2744)

Trp Pro Val Asp

C25H33N5O7 (515.238)

Trp Thr Ile Pro

C26H37N5O6 (515.2744)

Trp Thr Leu Pro

C26H37N5O6 (515.2744)

Trp Thr Pro Ile

C26H37N5O6 (515.2744)

Trp Thr Pro Leu

C26H37N5O6 (515.2744)

Trp Val Asp Pro

C25H33N5O7 (515.238)

Trp Val Pro Asp

C25H33N5O7 (515.238)

GDIVI

C23H41N5O8 (515.2955)

LGDVI

C23H41N5O8 (515.2955)

GANVR

C20H37N9O7 (515.2816)

GVVEI

C23H41N5O8 (515.2955)

LTPDA

C22H37N5O9 (515.2591)

AAQNL

C21H37N7O8 (515.2703)

PC(18:4/0:0)

C26H46NO7P (515.3012)

Tauro-b-muricholate

C26H45NO7S (515.2917)

Tauroursocholate

C26H45NO7S (515.2917)

Taurallocholic acid

C26H45NO7S (515.2917)

LPC(18:4)

C26H46NO7P (515.3012)

PC(18:4(6Z,9Z,12Z,15Z)/0:0)

C26H46NO7P (515.3012)

2-((6R,8aS)-4,6-dihydroxy-2,5,5,8a-tetramethyl-6-oxo-3,4,4a,5,6,6,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-7(3H)-yl)pentanedioic acid

C28H37NO8 (515.2519)

LPC 18:4

C26H46NO7P (515.3012)

ST 24:1;O5;T

C26H45NO7S (515.2917)

N,N,N-[(2,4,6,8,8-pentamethylcyclotetrasiloxane-2,4,6-triyl) tris(oxy)]tris[N-ethyl-Ethanamine

C17H45N3O7Si4 (515.2334)

Cephalotaxine,3-[4-methyl (2R)-2-hydroxy-2-(3-methylbutyl)butanedioate]

C28H37NO8 (515.2519)

Perphenazine enanthate

C28H38ClN3O2S (515.2373)

Lisavanbulin

C26H29N9O3 (515.2393)

D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

Benzenamine, 4,4-((4-(phenylimino)-2,5-cyclohexadien-1-ylidene)methylene)bis(N-phenyl-

C37H29N3 (515.2361)

N-(3alpha,6alpha,7beta-trihydroxy-5beta-cholan-24-oyl)-taurine

C26H45NO7S (515.2917)

2,3,4,5-Tetradehydroprolyl-2-aminobutanoyl-seryl-3-phenyl-beta-alanyl-2-aminobutanoic acid

C25H33N5O7 (515.238)

81-24-3

C26H45NO7S (515.2917)

D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats. Taurocholic acid (N-Choloyltaurine) is a bile acid involved in the emulsification of fats.

Tauro-beta-muricholic acid

C26H45NO7S (515.2917)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts A bile acid taurine conjugate derived from beta-muricholic acid. D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

CID 8959

C26H45NO7S (515.2917)

2-[[(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid

C26H45NO7S (515.2917)

3-deoxycarbamoylkanamycin C

C19H41N5O11+4 (515.2802)

N5-2,4-diaminobutanoate-N1-citryl-N3-dec-2-enoyl-N3-hydroxy-1,3-diaminopropane

C23H39N4O9- (515.2717)

pseudomonate B

C26H43O10- (515.2856)

2-(4-acetamido-N-[2-(benzotriazol-1-yl)acetyl]anilino)-N-(2-methylbutan-2-yl)-2-(1-methylpyrrol-2-yl)acetamide

C28H33N7O3 (515.2645)

N-(3alpha,6beta,7alpha-trihydroxy-5beta-cholan-24-oyl)-taurine

C26H45NO7S (515.2917)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-[4-[(3-methylphenyl)methoxy]phenyl]methylideneamino]-5-(piperidin-1-ylmethyl)triazole-4-carboxamide

C26H29N9O3 (515.2393)

5-(Dodecylamino)-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid

C32H37NO5 (515.2672)

CID 6436286

C28H37NO8 (515.2519)

2-[(4R)-4-[(2S,5R,7R,9R,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid

C26H45NO7S (515.2917)

N-[(5S,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C28H35F2N3O4 (515.2595)

N-[(5R,6S,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C28H35F2N3O4 (515.2595)

N-[(5R,6R,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C28H35F2N3O4 (515.2595)

N-[(5S,6R,9S)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C28H35F2N3O4 (515.2595)

N-[(5R,6S,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C28H35F2N3O4 (515.2595)

N-[(5R,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

N-[(5R,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

N-[(5S,6R,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-phenylphenyl)methyl]acetamide

C30H33N3O5 (515.242)

(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(pyridin-4-ylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C29H30FN5O3 (515.2333)

2-((4R)-4-((3R,5S,7R,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

2-((R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

N-[(5R,6R,9R)-8-[(2,5-difluorophenyl)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C28H35F2N3O4 (515.2595)

N-[(5S,6R,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

N-[(5S,6S,9S)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

N-[(5S,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

N-[(5R,6S,9R)-8-[(2-fluorophenyl)-oxomethyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

4-fluoro-N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C27H34FN3O6 (515.2432)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(4-phenylphenyl)methyl]acetamide

C30H33N3O5 (515.242)

(1S)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(pyridin-4-ylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C29H30FN5O3 (515.2333)

(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-(2-pyridinylmethyl)-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]carboxamide

C29H30FN5O3 (515.2333)

2-((4R)-4-((3R,5S,7R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid

C26H45NO7S (515.2917)

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methylbenzenesulfonamide

C27H37N3O5S (515.2454)

2-[4-[(3R,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C26H45NO7S (515.2917)

2-[[(4R)-4-[(3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid

C26H45NO7S (515.2917)

[(1S,3R,4R,5R,6R,7S,8R,11S,13R,16R,17R)-6-hydroxy-16-(1-hydroxyethyl)-13-methoxy-5,17,19-trimethyl-14-oxo-2,15-dioxatetracyclo[9.8.0.01,7.03,8]nonadeca-9,18-dien-4-yl] 1H-pyrrole-2-carboxylate

C28H37NO8 (515.2519)

[2-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H46NO7P (515.3012)

Lnape 2:0/N-18:4

C25H42NO8P (515.2648)

Lnape 18:4/N-2:0

C25H42NO8P (515.2648)

[2-acetyloxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H46NO7P (515.3012)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] pentanoate

C26H46NO7P (515.3012)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] propanoate

C26H46NO7P (515.3012)

2-[4-[(3R,5S,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C26H45NO7S (515.2917)

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C25H42NO8P (515.2648)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C25H42NO8P (515.2648)

2-[4-[(3R,5S,7R,8R,9S,12S,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C26H45NO7S (515.2917)

2-[4-[(3R,5R,6R,7S,8S,9S,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid

C26H45NO7S (515.2917)

[(2R)-2-hydroxy-3-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C26H46NO7P (515.3012)

Taurohyocholate

C26H45NO7S (515.2917)

2-[4-(3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonic acid

C26H45NO7S (515.2917)

LysoPC(18:4(6Z,9Z,12Z,15Z))

C26H46NO7P (515.3012)

2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid

C26H45NO7S (515.2917)

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

1-(9E,11E,13E,15E-octadecatetraenoyl)-sn-glycero-3-phosphocholine

C26H46NO7P (515.3012)

phosphatidylethanolamine 20:4 zwitterion

C25H42NO8P (515.2648)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 20 carbons and 4 double bonds.

lysophosphatidylcholine 18:4

C26H46NO7P (515.3012)

A lysophosphatidylcholine in which the acyl group (position not specified) contains 18 carbons and 4 double bonds.

Tauro-omega-muricholic acid

C26H45NO7S (515.2917)

LNAPE 20:4

C25H42NO8P (515.2648)

LPE 21:4

C26H46NO7P (515.3012)

LPE 20:5;O

C25H42NO8P (515.2648)

PE 18:4/2:0

C25H42NO8P (515.2648)

PE 20:4

C25H42NO8P (515.2648)

ST 26:6;O6;Gly

C28H37NO8 (515.2519)

ST 27:5;O5;Gly

C29H41NO7 (515.2883)

ST 20:5;O3;HexNAc

C28H37NO8 (515.2519)

ST 21:4;O2;HexNAc

C29H41NO7 (515.2883)

ST 23:2;O5;Tau

C25H41NO8S (515.2553)

ST 24:1;O4;Tau

C26H45NO7S (515.2917)

ST 26:7;O3;Tau

C28H37NO6S (515.2341)

ST 27:6;O2;Tau

C29H41NO5S (515.2705)

MePC(16:4)

C25H42NO8P (515.2648)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

2-({1-hydroxy-3-[(2-{[(2e,4e)-1-hydroxy-4-methylhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoyl)oxy]-2-methylbutylidene}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid

C27H37N3O7 (515.2631)

11-(acetyloxy)-3a,7-dihydroxy-1-(1-hydroxyethyl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl pyridine-3-carboxylate

C29H41NO7 (515.2883)

(1s,3r,4r,5r,6r,7s,8r,11s,13s,16s,17r)-6-hydroxy-16-[(1r)-1-hydroxyethyl]-13-methoxy-5,17,19-trimethyl-14-oxo-2,15-dioxatetracyclo[9.8.0.0¹,⁷.0³,⁸]nonadeca-9,18-dien-4-yl 1h-pyrrole-2-carboxylate

C28H37NO8 (515.2519)

(2s)-2-{[(2s)-2-{[(2s)-1,3-dihydroxy-2-{[(2s)-1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanoic acid

C25H33N5O7 (515.238)

2-({3-[(1,3-dihydroxy-2-{[1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene)amino]-1-hydroxy-3-phenylpropylidene}amino)butanoic acid

C25H33N5O7 (515.238)

(1r,2r,6r,10s,11r,13s,14r,15r)-13-(acetyloxy)-1-hydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-14-yl 2-(dimethylamino)-3-methylbut-2-enoate

C29H41NO7 (515.2883)

(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3s)-3-hydroxy-3-(3-methylbutyl)butanedioate

C28H37NO8 (515.2519)

2-{4,6'-dihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl}pentanedioic acid

C28H37NO8 (515.2519)

2-({2-[(1,3-dihydroxy-2-{[1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene)amino]-1-hydroxy-3-phenylpropylidene}amino)butanoic acid

C25H33N5O7 (515.238)

(2s,3s,6s)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3r)-3-hydroxy-3-(3-methylbutyl)butanedioate

C28H37NO8 (515.2519)

(2s)-2-{[(3s)-3-{[(2s)-1,3-dihydroxy-2-{[(2s)-1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanoic acid

C25H33N5O7 (515.238)

2-{[1-hydroxy-3-({2-[(1-hydroxy-4-methylhexa-2,4-dien-1-ylidene)amino]-3-phenylbutanoyl}oxy)-2-methylbutylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid

C27H37N3O7 (515.2631)

(1s)-1-[(1s,3ar,3bs,7r,9ar,9br,11r,11as)-11-(acetyloxy)-1,3a,3b,7-tetrahydroxy-9a-methyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl]ethyl pyridine-2-carboxylate

C28H37NO8 (515.2519)

(2s)-2-[(2r,2'r,4'as,6's,7'r,8'as)-4,6',7'-trihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl]-4-methylpentanoic acid

C29H41NO7 (515.2883)

1-[11-(acetyloxy)-1,3a,3b,7-tetrahydroxy-9a-methyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-yl]ethyl pyridine-2-carboxylate

C28H37NO8 (515.2519)

4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl 3-hydroxy-3-(3-methylbutyl)butanedioate

C28H37NO8 (515.2519)

(2s)-2-[(2r,2'r,4'as,6'r,8'as)-4,6'-dihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl]pentanedioic acid

C28H37NO8 (515.2519)

2-{4,6'-dihydroxy-2',5',5',8'a-tetramethyl-7-oxo-3,3',4',4'a,5,6',7',8'-octahydro-2'h-spiro[furo[2,3-f]isoindole-2,1'-naphthalen]-6-yl}pentanedioic acid

C28H37NO8 (515.2519)

(2s)-2-{[(3r)-3-{[(2s)-1,3-dihydroxy-2-{[(2s)-1-hydroxy-2-(1h-pyrrol-2-ylformamido)butylidene]amino}propylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanoic acid

C25H33N5O7 (515.238)

(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3r)-3-hydroxy-3-(3-methylbutyl)butanedioate

C28H37NO8 (515.2519)

(1r,3ar,3bs,5as,7s,9as,9bs,10s,11r,11ar)-11-(acetyloxy)-3a,7-dihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-10-yl pyridine-3-carboxylate

C29H41NO7 (515.2883)

(2s,3s)-2-[(2r,2'r,4'as,6's,7'r,8'as)-4,6',7'-trihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl]-3-methylpentanoic acid

C29H41NO7 (515.2883)

(3s,6s)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3r)-3-hydroxy-3-(3-methylbutyl)butanedioate

C28H37NO8 (515.2519)

(2s)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0²,⁶.0⁶,¹⁰.0¹⁵,¹⁹]icosa-1(20),4,13,15(19)-tetraen-3-yl 1-methyl (3s)-3-hydroxy-3-(3-methylbutyl)butanedioate

C28H37NO8 (515.2519)

4-methyl-2-{4,6',7'-trihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl}pentanoic acid

C29H41NO7 (515.2883)

(2s)-2-[(2s,2's,4'as,6'r,8'as)-4,6'-dihydroxy-2',5',5',8'a-tetramethyl-7-oxo-3,3',4',4'a,5,6',7',8'-octahydro-2'h-spiro[furo[2,3-f]isoindole-2,1'-naphthalen]-6-yl]pentanedioic acid

C28H37NO8 (515.2519)

(4r)-4-[(1r,3as,3br,4r,5as,7r,9as,9bs,11s,11ar)-4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-n-(2-sulfoethyl)pentanimidic acid

C26H45NO7S (515.2917)

3-methyl-2-{4,6',7'-trihydroxy-2',5',5',8'a-tetramethyl-6-oxo-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-7-yl}pentanoic acid

C29H41NO7 (515.2883)